Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Téléréadaptation à plusieurs composants pour impliquer les vétérans dans l'autogestion efficace de problèmes de santé complexes

5 novembre 2026 mis à jour par: VA Office of Research and Development

Téléréadaptation à plusieurs composants pour engager les vétérans dans une autogestion efficace des problèmes de santé complexes

Medically complex older Veterans are at greater risk for progressive declines in physical function, lower quality of life, and increasing care needs. Additionally, older Veterans experience social isolation and loneliness, and have low levels of physical activity. While the Veterans Health Administration has established programs to address rehabilitation needs, these programs tend to be diagnosis-focused, lack self-management approaches, include low-intensity rehabilitation, and typically require in-person attendance. A MultiComponent TeleRehabilitation (MCTR) program that includes high-intensity rehabilitation and self-management interventions, social support, and telehealth and technology supports may be more effective in improving and sustaining physical function for older Veterans with complex health conditions. Therefore, this project is designed to determine whether the MCTR program improves strength and physical function more effectively than traditional interventions.

Aperçu de l'étude

Description détaillée

The proposed MultiComponent TeleRehabilitation (MCTR) program addresses current healthcare deficiencies by using a multicomponent approach that includes both high-intensity rehabilitation interventions and self-management interventions that are not part of traditional physical therapy interventions. Therefore, the investigators propose a two-arm, parallel randomized trial using a crossover study design to determine the effectiveness (AIM 1) of a 12-week multicomponent telerehabilitation program to improve physical function. The investigators will also measure Veterans' clinical outcomes to evaluate the effectiveness of the MCTR program to improve physical activity, health self-management, and self-reported health (AIM 2). Lastly, the investigators will explore the effects of the MCTR program on safety events such as emergency room visits, hospitalizations, falls, and other adverse events (AIM 3). Participants (n=126) will be randomized to MCTR or Control group using computer-generated random blocks, stratified by sex. The MCTR group will participate in the 24-week program consisting of 1) progressive, high-intensity rehabilitation, 2) self-management interventions, 3) social support, and 4) technology supports. The 12-week program is split into three phases: the Active Phase (weeks 1-6), the Transition Phase (weeks 7-12), and the Sustainability Phase (weeks 13-24). The Control group will participate in education and health status update sessions in parallel to the MCTR 12-week program. Outcomes will be collected at baseline, 6 weeks, 12 weeks (primary endpoint), and 24 weeks. Achievement of the proposed aims will provide evidence to expand high quality telerehabilitation services for medically complex older Veterans with multiple factors contributing to poor health (e.g., social isolation, loneliness, physical inactivity, poor self-management). Importantly, results will guide the advancement of rehabilitation practices, moving away from a traditionally narrow, episodic, diagnosis-focused approach to a model emphasizing whole health self-management and sustained healthy living. Study findings will have immediate clinical impact as they will be directly translatable to other medically complex and underserved populations who will benefit from innovative telerehabilitation care approaches.

Type d'étude

Interventionnel

Inscription (Estimé)

126

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

Sauvegarde des contacts de l'étude

Lieux d'étude

    • Colorado
      • Aurora, Colorado, États-Unis, 80045-7211
        • Recrutement
        • Rocky Mountain Regional VA Medical Center, Aurora, CO
        • Chercheur principal:
          • Jennifer E. Stevens-Lapsley, PhD
        • Contact:

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

60 ans et plus (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • 60 years of age and older
  • Multiple chronic conditions (Functional Comorbidity Index > or = 3)
  • Impaired physical function (< or = 8 repetitions on 30 second sit to stand test)

Exclusion Criteria:

  • Life expectancy < 12 months
  • Acute or progressive neurological disorder (e.g. amyotrophic lateral sclerosis, recent stroke)
  • Moderate to severe dementia (<11 on telephone Montreal Cognitive Assessment(T-MoCA))
  • Medical conditions precluding safe participation in high-intensity rehabilitation (e.g. unstable angina)

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Traitement
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Multicomponent Telerehabilitation Intervention (Group 1)

Veterans randomized to the MCTR group will complete the 24-week study intervention consisting of the Active (weeks 1-6), Transition (weeks 7-12), and Sustainability (weeks 13-24) phases. Participants will receive a total of 16 individual sessions (6 integrated, 4 high-intensity rehabilitation, and 6 self-management intervention sessions).

Motivational Interviewing Techniques including but not limited to open-ended questions, reflection, affirmations, and summary will be used to build participant rapport, support behavior change (physical activity), and facilitate program engagement.

Strengthening, balance, functional activities, stretching, breathing, aerobic endurance exercise.

Autre: Education Control (Group 2)

This group will not receive any exercise intervention but will complete 16 sessions with research staff through videoconferencing. These visits will consist of standardized Health Status Update and education sessions on general health topics.

Education on general health topics which may include the following: basic nutrition, stress reduction, sleep hygiene, etc.

Health Status Updates will be completed by a trained assessor. The assessor will ask about adverse events, general health topics, medication changes, and changes in social circumstances.

Participants in the control condition will be offered a physical therapy consult at the end of their 24 week study involvement.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
2 Minute Step Test
Délai: Change from baseline to 6 weeks, 12 weeks, and 24 weeks compared to the control group.

This is a functional performance test for aerobic endurance. It requires participants to march in place for 2 minutes (alternating legs), and the score is the number of repetitions completed on the right leg. Scores are continuous, and higher scores indicate better aerobic endurance.

Change from baseline to 6 weeks, 12 weeks, and 24 weeks compared to the control group.

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Arm Curl Test
Délai: Change from baseline to 6 weeks, 12 weeks, and 24 weeks compared to the control group.

This is a functional performance test for upper body strength and is performed on each arm (one arm at a time). It requires the participant to perform as many arm curls (biceps curls) as possible in 30 seconds. Males use a 8 pound weight and females use a 5 pound weight. Scores are continuous, and higher scores indicate greater arm strength (better outcome)

Change from baseline to 6 weeks, 12 weeks, and 24 weeks compared to the control group.
30 Second Sit To Stand
Délai: Change from baseline to 6 weeks, 12 weeks, and 24 weeks compared to the control group.

The test uses a standard height chair and requires the participant to stand up and sit down as many times as possible in 30 seconds. More repetitions indicate better lower extremity strength.

Change from baseline to 6 weeks, 12 weeks, and 24 weeks compared to the control group.
Physical Activity
Délai: Will be collected at Baseline, 12 weeks, and 24 weeks.

Physical activity will be measured via accelerometry and will include an averaged daily step count.

Will be collected at Baseline, 12 weeks, and 24 weeks.
Exercise readiness to change
Délai: Change from baseline to 6 weeks, 12 weeks, and 24 weeks compared to the control group.

Four-item survey collected via interview format, and it is used to categorize participants into stages of change according to the Transtheoretical Model, possible stages include: (pre-contemplating, contemplation, preparation, action, and maintenance).

Change from baseline to 6 weeks, 12 weeks, and 24 weeks compared to the control group.
Self-efficacy for Exercise Scale
Délai: Change from baseline to 6 weeks, 12 weeks, and 24 weeks compared to the control group.

A 9-item survey, each item is scored on a scale of 0 (not confident) to 10 (very confident) and higher scores indicate greater self-efficacy.

Change from baseline to 6 weeks, 12 weeks, and 24 weeks compared to the control group.
Self-efficacy of Managing Chronic Conditions
Délai: Change from baseline to 6 weeks, 12 weeks, and 24 weeks compared to the control group.

A 8-item survey rated on a 5-point Likert scale [I am not at all confident (1) to I am very confident (5)], and higher scored indicates better self-efficacy.

Change from baseline to 6 weeks, 12 weeks, and 24 weeks compared to the control group.
The Patient-Specific Functional Scale
Délai: Change from baseline to 6 weeks, 12 weeks, and 24 weeks compared to the control group.

This is a questionnaire collected via interview format that quantifies activity or participation limitations that are important to the patient. Each participant identifies 3 activities that are important and that they are currently unable to do or having difficult performing due to their health; each item is then rated on a 0 (unable to preform activity) 0 to 10 (able to perform activity at the same level as before injury or problem) scale. The total score is an average of the 3 activities.

Change from baseline to 6 weeks, 12 weeks, and 24 weeks compared to the control group.
Activity Measure for Post-Acute Care (AM-PAC) basic mobility outpatient routine short form
Délai: Change from baseline to 6 weeks, 12 weeks, and 24 weeks compared to the control group.

This questionnaire consists of 18 items rated on a 4-point Likert scale in response to the prompt, "How much difficulty do you currently have..." Total scores range from 18 to 72 and higher scores indicate less difficulty with physical tasks.

Change from baseline to 6 weeks, 12 weeks, and 24 weeks compared to the control group.
Patient-Reported Outcomes Measurement Information System (PROMIS) 29+2 Profile v2.1 (PROPr) survey
Délai: Change from baseline to 6 weeks, 12 weeks, and 24 weeks compared to the control group.

This is a 29-item questionnaire, and most items are rated on a 5-point Likert scale. There is one pain intensity item rated on a 0 (no pain) to 10 (worst pain imaginable) scale. Higher scores indicate more of the concept being measured.

Change from baseline to 6 weeks, 12 weeks, and 24 weeks compared to the control group.
Patient-Reported Outcomes Measurement Information System (PROMIS) v2 social isolation short form (SF) 8a
Délai: Change from baseline to 6 weeks, 12 weeks, and 24 weeks compared to the control group.

An 8-item questionnaire rated on a 1 (never) to 5 (always) Likert scale. Higher scores indicate greater perceptions of loneliness and isolation, which is considered a worse outcome.

Change from baseline to 6 weeks, 12 weeks, and 24 weeks compared to the control group.
Patient-Reported Outcomes Measurement Information System (PROMIS) satisfaction with participation in discretionary social activities short form (SF) 7a
Délai: Change from baseline to 6 weeks, 12 weeks, and 24 weeks compared to the control group.

Includes 7 items rated on a 1 (not at all) to 5 (very much) Likert scale. Higher scores indicate greater satisfaction with discretionary social activities.

Change from baseline to 6 weeks, 12 weeks, and 24 weeks compared to the control group.
Physical Activity and Social Support Scale
Délai: Change from baseline to 6 weeks, 12 weeks, and 24 weeks compared to the control group.

A 20 -item survey rated on a scale of 1 (never true) to 7 (always true) that measures emotional, informational, instrumental, validation, and companionship support related to physical activity. Higher scores indicated greater levels of perceived social support.

Change from baseline to 6 weeks, 12 weeks, and 24 weeks compared to the control group.
Geriatric Pain Measure
Délai: Change from baseline to 6 weeks, 12 weeks, and 24 weeks compared to the control group.

Consists of 22 items scored as yes (1 point) or no (0 points) that assess whether or not a person does or would have pain during activities. There are also 2 items measured on a scale of 0 (no pain) to 10 (worst pain). Total scores range from 0-42 and adjusted scores range from 0-100 with higher scores indicating worse pain.

Change from baseline to 6 weeks, 12 weeks, and 24 weeks compared to the control group.
Pain Coping Inventory
Délai: Change from baseline to 6 weeks, 12 weeks, and 24 weeks compared to the control group.

This measures both active (transformation, distraction, reducing demands) and passive (retreating, worrying, resting) coping strategies. The inventory includes 34 items rated on a scale from 1 (hardly ever) to 4 (very often). Higher scores indicate more frequent use of each specific coping strategy.

Change from baseline to 6 weeks, 12 weeks, and 24 weeks compared to the control group.

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chercheur principal: Jennifer E. Stevens-Lapsley, PhD, Rocky Mountain Regional VA Medical Center, Aurora, CO

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

18 avril 2024

Achèvement primaire (Estimé)

1 février 2027

Achèvement de l'étude (Estimé)

30 juin 2028

Dates d'inscription aux études

Première soumission

23 février 2024

Première soumission répondant aux critères de contrôle qualité

23 février 2024

Première publication (Réel)

1 mars 2024

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

9 novembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

5 novembre 2026

Dernière vérification

1 novembre 2026

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • E5012-R
  • 23-2306 (Autre identifiant: COMIRB)
  • 5I01RX005012-03 (Subvention/contrat des NIH des États-Unis)

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

produit fabriqué et exporté des États-Unis.

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner